CICCARELLI, NICOLETTA
 Distribuzione geografica
Continente #
EU - Europa 1.585
NA - Nord America 230
AS - Asia 93
AF - Africa 3
OC - Oceania 1
Totale 1.912
Nazione #
RU - Federazione Russa 1.416
US - Stati Uniti d'America 229
IT - Italia 90
SG - Singapore 84
DE - Germania 23
FR - Francia 16
AT - Austria 10
GB - Regno Unito 9
FI - Finlandia 8
IE - Irlanda 6
NL - Olanda 5
HK - Hong Kong 4
IL - Israele 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
CA - Canada 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EG - Egitto 1
SC - Seychelles 1
TM - Turkmenistan 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 1.912
Città #
Moscow 131
The Dalles 53
Chicago 45
Castelgomberto 38
Singapore 37
Santa Clara 36
Rome 23
Buffalo 16
Elk Grove Village 16
Secaucus 15
Yubileyny 13
Lauterbourg 12
Portsmouth 9
Assago 8
Helsinki 8
Nuremberg 8
Dublin 6
Milan 5
Cagliari 4
Pasadena 4
Salerno 4
Hong Kong 3
Los Angeles 3
Boydton 2
Cologno Monzese 2
Düsseldorf 2
Vienna 2
West Jordan 2
Ashburn 1
Ashgabat 1
Brescia 1
Cairo 1
Liberty Lake 1
Pavia 1
Prague 1
San Francisco 1
San Jose 1
Tallinn 1
Totale 517
Nome #
Hepatitis C virus-related factors associated WITH cognitive performance in HIV-HCV-coinfected patients 65
Degenerative and Vascular Fluent Aphasia: Looking for Differences 63
Health-related quality of life (HRQoL) from HIV patients’ perspective: comparison of patient-reported outcome (PRO) measures among people living with hiv (PLWH) and other chronic clinical conditions 61
Cognitive reserve and neuropsychological functioning in older HIV-infected people 60
Cognitive impairment and cardiovascular disease related to alexithymia in a well-controlled HIV-infected population 60
Cognitive reserve: a multidimensional protective factor in Parkinson’s disease related cognitive impairment 58
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 53
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 53
Cardiovascular risk factors and carotid intima-media thickness are associated with lower cognitive performance in HIV-infected patients 52
Efficacy and safety of treatment simplification to atazanavir/ritonavir1lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study 51
Treatment simplification to atazanavir/ritonavir+lamivudine versus maintenance of atazanavir/ritonavir+two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M) 50
Considerations on nosology for HIV-associated neurocognitive disorders: it is time to update? 50
The facial emotion recognition deficit in Parkinson’s disease: Implications of a visual scanning strategy 50
Evaluation of emotion processing in HIV-infected patients and correlation with cognitive performance 49
Differences in the Long-term Impact of the COVID-19 Pandemic on the Mental Health and Professional Quality of Life of Resident and Specialist Physicians 49
Emotional valence may influence memory performance for visual artworks in Parkinson’s disease 48
Posterior AD-Type pathology: Cognitive subtypes emerging from a cluster analysis 45
Baseline CD4+ T-cell count and cardiovascular risk factors predict the evolution of cognitive performance during 2-year follow-up in HIV-infected patients 45
Naming of grammatical classes in frontotemporal dementias: Linguistic and non linguistic factors contribute to noun-verb dissociation 44
Effects of stimulation of the subthalamic nucleus on naming and reading nouns and verbs in Parkinson's disease 43
Safety and feasibility of treatment simplification to atazanavir/ ritonavir1lamivudine in hiv-infected patients on stable treatment with two nucleos(t)ide reverse transcriptase inhibitors1atazanavir/ ritonavir with virological suppression (atazanavir and lamivudine for treatment simplification, atlas pilot study) 43
Psychological distress during the initial stage of the COVID-19 pandemic in an Italian population living with HIV: an online survey 43
Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) 42
Effect of aging and human immunodeficiency virus infection on cognitive abilities 42
Safety and efficacy of treatment switch to raltegravir plus tenofovir/emtricitabine or abacavir/lamivudine in patients with optimal virological control: 48-week results from a randomized pilot study (Raltegravir Switch for Toxicity or Adverse Events, RASTA Study) 42
Primary progressive aphasia: Linguistic patterns and clinical variants 41
HIV-Related Internalized Stigma and Patient Health Engagement Model in an Italian Cohort of People Living With HIV 41
The deficit for the word-class "verb" in corticobasal degeneration: Linguistic expression of the movement disorder? 41
Comparison of cognitive performance in HIV or HCV mono-infected and HIV-HCV co-infected patients 40
Impact of the COVID-19 Pandemic on Health Care Is Negatively Associated With Psychosocial Well-Being in an Italian Cohort of People Living With HIV 40
The role of cognitive reserve in cognitive aging: what we can learn from Parkinson’s disease 39
Unilateral Spatial Neglect in Degenerative Brain Pathology 37
Use of telehealth for HIV care in Italy: Are doctors and patients on the same page? A cross-sectional study 37
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 37
Total cellular HIV-1 DNA decreases after switching to raltegravir-based regimens in patients with suppressed HIV-1 RNA 37
Difference in the neurocognitive functions of WLWH and MLWH in an Italian cohort of people living with HIV 37
Verbal list learning and memory profiles in HIV-infected adults, Alzheimer’s disease, and Parkinson’s disease: An evaluation of the “cortical hypothesis” of NeuroAIDS 36
Semantic memory in object use 36
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 36
Increased ophthalmic artery resistance index is associated with cognitive impairment in HIV-infected patients 34
Writing errors in primary progressive aphasia 33
SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV 33
Liver fibrosis is associated with cognitive impairment in people living with HIV 32
Revised central nervous system neuropenetrationeffectiveness score is associated with cognitive disorders in HIV-infected patients with controlled plasma viraemia 31
Totale 1.959
Categoria #
all - tutte 6.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.410


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/20244 0 0 0 0 0 0 0 0 1 2 0 1
2024/20251.955 1 2 171 17 59 155 1.068 357 104 21 0 0
Totale 1.959